The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a https://graysonnktg608747.ivasdesign.com/59934493/retatrutide-vs-tirzepatide-a-comparative-analysis